Promising research studies surrounding the medication Retatrutide , specifically the high-dose formulation branded as ZPHC, suggest a significant benefit on body mass reduction and related chronic conditions . Researchers posit that this combined compound, targeting both GLP-1 and GIP pathways , could provide a noteworthy improvement in the treatm